Download FREE Report Sample
Download Free sampleDactinomycin is a mixture of Streptomyces chrysomallus, mainly composed of C1, C2, C3 and D.Red or orange-yellow crystalline powder of madder.Soluble in ethanol, acetone and benzene.Its effect is similar to that of actinomycin, and it has a wide antitumor spectrum.In addition, also has the strong resistance bacteria, fungi and viruses.It is mainly used for Hodgkin's disease, nephroblastoma and leukemia in children.The toxic and side effects are similar to those of actinomycin, mainly myelosuppression and gastrointestinal reactions.Advanced malignant tumors, low red and white blood cells and pregnant women are contraindicated.
Dactinomycin Market contains market size and forecasts of Dactinomycin in Global, including the following market information:
Global Dactinomycin Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Dactinomycin market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Dactinomycin include AstraZeneca, GSK, Recordati Rare Diseases, Lundbeck, Merck, Prasco Laboratories, X-GEN Pharmaceuticals, Mylan Institutional and Bedford Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Dactinomycin companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Dactinomycin Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Dactinomycin Market Segment Percentages, by Type, 2021 (%)
Injection
Implants
Global Dactinomycin Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Dactinomycin Market Segment Percentages, by Application, 2021 (%)
Alkylating Agent
Hormone
Plant Medicine
Global Dactinomycin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Dactinomycin Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Dactinomycin revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Dactinomycin revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
GSK
Recordati Rare Diseases
Lundbeck
Merck
Prasco Laboratories
X-GEN Pharmaceuticals
Mylan Institutional
Bedford Pharmaceuticals
HISUN
Hainan Jinrui Pharmaceutical
Qilu Pharmaceutical
Shanghai Zhongke Pharmaceutical
Shanghai Xinya Pharmaceutical
Nantong Xinhe Biotechnology
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
